about
HPV16 variant lineage, clinical stage, and survival in women with invasive cervical cancerPrognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: a Gynecologic Oncology Group study.A phase 2 study of alisertib (MLN8237) in recurrent or persistent uterine leiomyosarcoma: An NRG Oncology/Gynecologic Oncology Group study 0231D.Molecular mapping of high-grade cervical intraepithelial neoplasia shows etiological dominance of HPV16.The role of co-factors in the progression from human papillomavirus infection to cervical cancerPerformance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population.Risk of cervical intraepithelial neoplasia 2+ among women with a history of previous treatment for cervical intraepithelial neoplasia: ASCUS and LSIL Pap smears after treatment.Multiple biopsies and detection of cervical cancer precursors at colposcopy.Tubal ligation frequency in Oklahoma women with cervical cancer.Assessing the risk of ovarian malignancy algorithm for the conservative management of women with a pelvic massManagement of Low-Grade Cervical Müllerian Adenosarcoma in a 14-Year-Old Girl.Preemptive analgesia for postoperative hysterectomy pain control: systematic review and clinical practice guidelines.Salpingo-oophorectomy at the Time of Benign Hysterectomy: A Systematic Review.Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study.Identification of novel diagnostic and prognostic miRNA signatures in endometrial cancer.ASCCP Colposcopy Standards: Role of Colposcopy, Benefits, Potential Harms, and Terminology for Colposcopic Practice.Outcomes of cervical cancer and positive para-aortic lymph nodes in the modern era of chemoradiation.Evidence-Based Consensus Recommendations for Colposcopy Practice for Cervical Cancer Prevention in the United States.Gastric-Type Endometrial Adenocarcinoma: Report of Two Cases in Patients From the United States.Surgical outcomes among elderly women with endometrial cancer treated by laparoscopic hysterectomy: a NRG/Gynecologic Oncology Group study.Primary Ovarian Solid Pseudopapillary Neoplasm With CTNNB1 c.98C>G (p.S33C) Point Mutation.Willingness of gynecologic cancer patients to participate in clinical trials
P50
Q22299118-5AA8A990-4707-466F-8F5F-BB8AADE68E80Q30359038-BCF4BC05-08D8-4A82-BDBC-E282D3873760Q33438485-C338603B-DD66-4CDA-9EC8-2C69D9E786ECQ34196510-B1A64E73-FD6F-40A4-96E7-81C667425713Q34311313-3EFCAD06-D268-4A77-8940-2506027BC69BQ34543338-DA9A6E63-CE2D-4862-A13F-2CF822A1B7C6Q34636306-1A0A51C5-5BF6-4314-A745-960CEFB862E8Q34716608-8FC7F67A-CBAA-4DF4-8DD7-0E30A1BD0792Q36319790-A2F3C806-E66A-40D0-A65F-305E520DDFD6Q36904090-767B63E4-B511-48D5-A8B1-D3024B8BD8EEQ38675189-C51F16AA-8B96-436D-9316-7A49310AA5BFQ38870479-E18741EE-ECDC-44B6-B91B-26F8F0465F3BQ38921548-7CBA3BB6-13BD-4389-B0C2-F00DAFAA9028Q39123683-A76721FF-53CE-4F9C-878E-5C81DDC306F4Q41024459-955EE8B4-BBB7-4378-BF8F-9CDCF7294478Q42693516-651D0A5C-18D6-40CE-8F70-E0E9305661B5Q43779832-BF388BD1-12C0-4925-A0D3-B87E29E8A43FQ45068520-4908B736-4ADD-40FC-85F8-CE74B3BA0158Q48341401-EA91DC0D-23CC-4B6F-9A05-83C4278CAEF9Q50076051-324E7BEB-9609-4F48-9048-11D699CA0B6BQ53730617-63B9702B-E386-4745-BCA0-DD952B823BD2Q60139633-431D217A-48C0-4A61-9712-780883A4DEBC
P50
description
researcher ORCID ID = 0000-0001-8461-4568
@en
wetenschapper
@nl
name
Cara Mathews
@ast
Cara Mathews
@en
Cara Mathews
@es
Cara Mathews
@nl
type
label
Cara Mathews
@ast
Cara Mathews
@en
Cara Mathews
@es
Cara Mathews
@nl
prefLabel
Cara Mathews
@ast
Cara Mathews
@en
Cara Mathews
@es
Cara Mathews
@nl
P106
P1153
37100063900
P31
P496
0000-0001-8461-4568